Genomic Biomarkers, By Indication (Oncology, Cardiovascular diseases, Neurological diseases), By End User (Hospitals, Diagnostic & Research Laboratories) and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2022-2028


 Request Customization  Sample Request  Ask for Discount
 MDHE9MXBC1MW  |    Mar 16, 2020


A biomarker is the measurable biological indicator of the health condition of the individuals. The biomarker is used to measure the risk of particular diseases in the human body. Traditionally, biomarkers referred to physiological traits, however with the emergence of technological advancement in diagnostics measures, the biomarker is referred to as a product of genomic, metabolomic, and proteomic research. Genomics is the study of intragenomic processes including pleiotropy, epistasis, and heterosis as well as the interactions between alleles and loci within the genome. Genomics study is important in the field of molecular biology and genetics. Genome is the DNS content that is present in one cell of an organism. In genomics, the experts strive to determine the complete DNA sequence and perform the genetic map to diagnose the disease. Therefore, the genomic biomarker is used across a wide range of applications including Oncology, Cardiovascular diseases, Neurological diseases, and others.



The report offers detailed coverage of Genomic Biomarkers market and industry trends to provide a comprehensive view of the market. The Genomic Biomarkers research report includes market estimation & forecasting, demand & supply analysis, price trends, company market share of the leading players in Genomic Biomarkers market. The report splits the market based on various segments. The Genomic Biomarkers market report also describes the main players and how they are strengthening their position in the market with the latest innovations, strategic acquisitions, partnership and collaboration. It also provides the financial analysis, SWOT analysis, company overview and portfolio analysis of the leading players in the Genomic Biomarkers market. 

  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Myriad Genetics
  • QIAGEN
  • Bio-Rad Laboratories
  • US Biomarkers Inc.
  • Almac Group
  • Epigenomics AG

Genomic Biomarkers Segments

The Genomic Biomarkers market is segmented as below

Segmentation

Indication

  • Oncology
  • Cardiovascular diseases
  • Neurological diseases

End User

  • Hospitals
  • Diagnostic & Research Laboratories

The Genomic Biomarkers market report brings market data at one point to understand the Genomic Biomarkers market growth trends, market size, and future scenario of the market. This analysis will help clients to plan their expansion, investment, merger acquisition strategy and bring the improvement. All the data of Genomic Biomarkers market is demonstrated in such a way that the end-user can leverage the analyzed data. The analysis includes all segment and sub-segment analysis and their scope, growth rate, market opportunities and challenges. 



The qualitative analysis of Genomic Biomarkers market report includes competitive landscape, key growth, and restraining factors. In addition to this, the PESTEL, Porter's Five, and Value chain analysis enables users to understand how the micro and macro-economic factors have influenced the Genomic Biomarkers market.  The global analysis of Genomic Biomarkers market report allows users to understand the competitive factors in the market, which help them to take strategic business decisions for sustainable growth. 

In Genomic Biomarkers market report the top-down and bottom-up approach has applied to estimate the market value. In the top-down and bottom-up approach, the report considered primary and secondary research. In the primary research, multiple interviews were conducted with CEOs, CFOs, and product managers of the leading players. The interviews also include the subject matter expert, investors, and end-user interviews. Secondary research includes company annual reports, press releases, whitepapers, market players’ association news portal, government portal, and journals. 

Market Density

Market Density is one-stop market research, advisory, consulting and, industry analysis reports platform. The reports' library providing business data and intelligence information on thousands of micro as well as high growth markets with global as well as regional coverage. Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for B2B, B2C, and government organizations around the globe. Market Density helps global clients to deal with the business challenges in the competitive world for sustainable growth.

Contact information:

4340 Stevens Creek Blvd,
Suite # 172.
San Jose, CA 95129
Ph : +1 669 264 1656
Email : sales@marketdensity.com

 

  • About Us
    • Why Should you buy this report (sample)
    • How this report delivers? (sample)
    • Key Questions Answered(sample)
  • Chapter 1: Introduction to Genomic Biomarkers Market
    • Market Definition
    • Market Segmentation
    • Macro Economic Factor Analysis
  • Chapter 2: Executive Summary
  • Chapter 3: Market Factor Analysis
    • Porter’s Five Forces Analysis
    • PESTEL Analysis
    • Value Chain Analysis
    • SWOT Analysis
    • Pricing Analysis
  • Chapter 4: Global Genomic Biomarkers Market Estimation & Forecast By Indication
    • Oncology
    • Cardiovascular diseases
    • Neurological diseases
  • Chapter 5: Global Genomic Biomarkers Market Estimation & Forecast By End User
    • Hospitals
    • Diagnostic & Research Laboratories
  • Chapter 6 Global Genomic Biomarkers Market Estimation & Forecast By Region
    • North America
    • Asia Pacific
    • Europe
    • EMEA
    • Latin America
  • Chapter 7 Competitive Landscape
    • Competition Mapping
    • Company Profiles (Suppliers)
      • Thermo Fisher Scientific
      • Roche Diagnostics
      • Myriad Genetics
      • QIAGEN
      • Bio-Rad Laboratories
      • US Biomarkers Inc.
      • Almac Group
      • Epigenomics AG
  • Chapter 8 Recommendations
  • Chapter 9 Acronyms and Assumptions

Purchase options

Single User $ 2100.00
Corporate User $ 3000.00